Exosome‐Loaded Engineered circBDNF Promotes Spinal Cord Injury Repair Through the PI3K / AKT / mTOR Signaling Axis
CNS Neuroscience & Therapeutics · 2026-03 · 32 (3)
DOI: 10.1002/cns.70784 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 19.03.2026. Verfasst von Gang Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Exosomes, Brain-Derived Neurotrophic Factor, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangzhou Science and Technology Program.
Abstract (Originalsprache)
Background
The brain‐derived neurotrophic factor (BDNF) is a potent neuroprotective factor; however, its large molecular size limits its ability to cross structural barriers such as the blood–spinal cord barrier. This study explores the therapeutic potential of exosome‐mediated delivery of engineered circular BDNF (circBDNF) to promote spinal cord injury (SCI) repair through activation of the PI3K/AKT/mTOR signaling pathway.
Methods
A synthetic circBDNF sequence encoding BDNF was used to construct a circBDNF overexpression plasmid, which was transfected into HEK293T cells to generate circBDNF‐loaded exosomes (circBDNF‐EXO). These exosomes were characterized via transmission electron microscopy, nanoparticle tracking analysis, and Western blotting. In vitro, the protective effects of circBDNF‐EXO were evaluated in an oxygen–glucose deprivation/reperfusion (OGD) injury model in HT22 cells, focusing on cell viability, reactive oxygen species (ROS) levels, apoptosis, inflammation, and signaling pathways. In vivo, a T10 SCI mouse model was employed to assess therapeutic efficacy, using behavioral, electrophysiological, histological, and molecular analyses.
Results
In vitro, circBDNF‐EXO treatment significantly increased BDNF expression, enhanced cell viability, reduced ROS levels, mitigated inflammation, and inhibited apoptosis in HT22 cells following OGD injury. In vivo, administration of circBDNF‐EXO resulted in improved motor function recovery, evidenced by increased Basso Mouse Scale scores, enhanced gait coordination, and better motor‐evoked potentials. Histological analyses demonstrated elevated BDNF expression, decreased apoptosis, reduced oxidative stress, and enhanced axonal regeneration in the injured spinal cord. Mechanistically, circBDNF‐EXO activated TrkB receptors and upregulated the PI3K/AKT/mTOR signaling pathway, as confirmed by Western blot analysis.
Conclusion
Exosome‐mediated delivery of circBDNF promotes SCI repair by activating the PI3K/AKT/mTOR pathway, suppressing apoptosis, oxidative stress, and inflammation, and enhancing axonal regeneration. This innovative approach holds substantial promise for SCI treatment and deserves further exploration in preclinical and clinical studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
- Department of Spinal Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, China.
- Guangdong Province Key Laboratory of Orthopaedics and Traumatology, Guangzhou, Guangdong, China.
- Department of Joint Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, People's Republic of China.
- Department of Neurosurgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, People's Republic of China.
ORCID-Profile: Gang Li, Yong Wan, Baoshu Xie
Förderung
- National Natural Science Foundation of China
- Guangzhou Science and Technology Program
Zitieren
APA
Li, G., Kong, G., Gu, C., Zhang, D., Wan, Y., & Xie, B. (2026). Exosome‐Loaded Engineered circBDNF Promotes Spinal Cord Injury Repair Through the PI3K / AKT / mTOR Signaling Axis. CNS Neuroscience & Therapeutics, 32(3). https://doi.org/10.1002/cns.70784
Vancouver
Li G, Kong G, Gu C, Zhang D, Wan Y, Xie B. Exosome‐Loaded Engineered circBDNF Promotes Spinal Cord Injury Repair Through the PI3K / AKT / mTOR Signaling Axis. CNS Neuroscience & Therapeutics. 2026;32(3). doi:10.1002/cns.70784
BibTeX
@article{Li2026,
author = {Li, Gang and Kong, Ganggang and Gu, Cheng and Zhang, Di and Wan, Yong and Xie, Baoshu},
title = {Exosome‐Loaded Engineered circBDNF Promotes Spinal Cord Injury Repair Through the PI3K / AKT / mTOR Signaling Axis},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {3},
doi = {10.1002/cns.70784}
}
EUVIMED